Global EGFR-TKI Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to EGFR-TKI: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global EGFR-TKI Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gefitinib
1.2.3 Erlotinib
1.2.4 Icotinib
1.2.5 Afatinib
1.2.6 Dacomitinib
1.2.7 Osimertinib
1.2.8 Aumolertinib
1.2.9 Furmonertinib
1.2.10 Lazertinib
1.3 Market Segmentation by Application
1.3.1 Global EGFR-TKI Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global EGFR-TKI Revenue Estimates and Forecasts 2020-2031
2.2 Global EGFR-TKI Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global EGFR-TKI Sales Estimates and Forecasts 2020-2031
2.4 Global EGFR-TKI Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global EGFR-TKI Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global EGFR-TKI Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Gefitinib Market Size by Manufacturers
3.5.2 Erlotinib Market Size by Manufacturers
3.5.3 Icotinib Market Size by Manufacturers
3.5.4 Afatinib Market Size by Manufacturers
3.5.5 Dacomitinib Market Size by Manufacturers
3.5.6 Osimertinib Market Size by Manufacturers
3.5.7 Aumolertinib Market Size by Manufacturers
3.5.8 Furmonertinib Market Size by Manufacturers
3.5.9 Lazertinib Market Size by Manufacturers
3.6 Global EGFR-TKI Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global EGFR-TKI Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global EGFR-TKI Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global EGFR-TKI Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global EGFR-TKI Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America EGFR-TKI Sales and Revenue by Type (2020-2031)
6.4 North America EGFR-TKI Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America EGFR-TKI Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe EGFR-TKI Sales and Revenue by Type (2020-2031)
7.4 Europe EGFR-TKI Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe EGFR-TKI Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific EGFR-TKI Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific EGFR-TKI Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific EGFR-TKI Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America EGFR-TKI Sales and Revenue by Type (2020-2031)
9.4 Central and South America EGFR-TKI Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America EGFR-TKI Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa EGFR-TKI Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa EGFR-TKI Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa EGFR-TKI Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca EGFR-TKI Product Models, Descriptions and Specifications
11.1.4 AstraZeneca EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 AstraZeneca EGFR-TKI Sales by Product in 2024
11.1.6 AstraZeneca EGFR-TKI Sales by Application in 2024
11.1.7 AstraZeneca EGFR-TKI Sales by Geographic Area in 2024
11.1.8 AstraZeneca EGFR-TKI SWOT Analysis
11.1.9 AstraZeneca Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Business Overview
11.2.3 Roche EGFR-TKI Product Models, Descriptions and Specifications
11.2.4 Roche EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Roche EGFR-TKI Sales by Product in 2024
11.2.6 Roche EGFR-TKI Sales by Application in 2024
11.2.7 Roche EGFR-TKI Sales by Geographic Area in 2024
11.2.8 Roche EGFR-TKI SWOT Analysis
11.2.9 Roche Recent Developments
11.3 Betta Pharma
11.3.1 Betta Pharma Corporation Information
11.3.2 Betta Pharma Business Overview
11.3.3 Betta Pharma EGFR-TKI Product Models, Descriptions and Specifications
11.3.4 Betta Pharma EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Betta Pharma EGFR-TKI Sales by Product in 2024
11.3.6 Betta Pharma EGFR-TKI Sales by Application in 2024
11.3.7 Betta Pharma EGFR-TKI Sales by Geographic Area in 2024
11.3.8 Betta Pharma EGFR-TKI SWOT Analysis
11.3.9 Betta Pharma Recent Developments
11.4 Boehringer Ingelheim Pharmaceuticals
11.4.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
11.4.2 Boehringer Ingelheim Pharmaceuticals Business Overview
11.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Models, Descriptions and Specifications
11.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales by Product in 2024
11.4.6 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales by Application in 2024
11.4.7 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales by Geographic Area in 2024
11.4.8 Boehringer Ingelheim Pharmaceuticals EGFR-TKI SWOT Analysis
11.4.9 Boehringer Ingelheim Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Business Overview
11.5.3 Pfizer EGFR-TKI Product Models, Descriptions and Specifications
11.5.4 Pfizer EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Pfizer EGFR-TKI Sales by Product in 2024
11.5.6 Pfizer EGFR-TKI Sales by Application in 2024
11.5.7 Pfizer EGFR-TKI Sales by Geographic Area in 2024
11.5.8 Pfizer EGFR-TKI SWOT Analysis
11.5.9 Pfizer Recent Developments
11.6 Chengdu Brilliant Pharmaceuticals
11.6.1 Chengdu Brilliant Pharmaceuticals Corporation Information
11.6.2 Chengdu Brilliant Pharmaceuticals Business Overview
11.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Models, Descriptions and Specifications
11.6.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Chengdu Brilliant Pharmaceuticals Recent Developments
11.7 Hansoh Pharma
11.7.1 Hansoh Pharma Corporation Information
11.7.2 Hansoh Pharma Business Overview
11.7.3 Hansoh Pharma EGFR-TKI Product Models, Descriptions and Specifications
11.7.4 Hansoh Pharma EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hansoh Pharma Recent Developments
11.8 ArriVent Biopharma
11.8.1 ArriVent Biopharma Corporation Information
11.8.2 ArriVent Biopharma Business Overview
11.8.3 ArriVent Biopharma EGFR-TKI Product Models, Descriptions and Specifications
11.8.4 ArriVent Biopharma EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ArriVent Biopharma Recent Developments
11.9 Hanmi Pharmaceutical
11.9.1 Hanmi Pharmaceutical Corporation Information
11.9.2 Hanmi Pharmaceutical Business Overview
11.9.3 Hanmi Pharmaceutical EGFR-TKI Product Models, Descriptions and Specifications
11.9.4 Hanmi Pharmaceutical EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hanmi Pharmaceutical Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson EGFR-TKI Product Models, Descriptions and Specifications
11.10.4 Johnson & Johnson EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Johnson & Johnson Recent Developments
11.11 Yuhan Corporation
11.11.1 Yuhan Corporation Corporation Information
11.11.2 Yuhan Corporation Business Overview
11.11.3 Yuhan Corporation EGFR-TKI Product Models, Descriptions and Specifications
11.11.4 Yuhan Corporation EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Yuhan Corporation Recent Developments
11.12 Shanghai Allist Pharmaceuticals
11.12.1 Shanghai Allist Pharmaceuticals Corporation Information
11.12.2 Shanghai Allist Pharmaceuticals Business Overview
11.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Product Models, Descriptions and Specifications
11.12.4 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Shanghai Allist Pharmaceuticals Recent Developments
11.13 Wanbang Biopharmaceuticals
11.13.1 Wanbang Biopharmaceuticals Corporation Information
11.13.2 Wanbang Biopharmaceuticals Business Overview
11.13.3 Wanbang Biopharmaceuticals EGFR-TKI Product Models, Descriptions and Specifications
11.13.4 Wanbang Biopharmaceuticals EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Wanbang Biopharmaceuticals Recent Developments
11.14 Beacon Pharma
11.14.1 Beacon Pharma Corporation Information
11.14.2 Beacon Pharma Business Overview
11.14.3 Beacon Pharma EGFR-TKI Product Models, Descriptions and Specifications
11.14.4 Beacon Pharma EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Beacon Pharma Recent Developments
11.15 Drug International
11.15.1 Drug International Corporation Information
11.15.2 Drug International Business Overview
11.15.3 Drug International EGFR-TKI Product Models, Descriptions and Specifications
11.15.4 Drug International EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Drug International Recent Developments
11.16 Teva
11.16.1 Teva Corporation Information
11.16.2 Teva Business Overview
11.16.3 Teva EGFR-TKI Product Models, Descriptions and Specifications
11.16.4 Teva EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Teva Recent Developments
11.17 Mylan
11.17.1 Mylan Corporation Information
11.17.2 Mylan Business Overview
11.17.3 Mylan EGFR-TKI Product Models, Descriptions and Specifications
11.17.4 Mylan EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Mylan Recent Developments
11.18 Glenmark Pharmaceuticals
11.18.1 Glenmark Pharmaceuticals Corporation Information
11.18.2 Glenmark Pharmaceuticals Business Overview
11.18.3 Glenmark Pharmaceuticals EGFR-TKI Product Models, Descriptions and Specifications
11.18.4 Glenmark Pharmaceuticals EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Glenmark Pharmaceuticals Recent Developments
11.19 Cipla
11.19.1 Cipla Corporation Information
11.19.2 Cipla Business Overview
11.19.3 Cipla EGFR-TKI Product Models, Descriptions and Specifications
11.19.4 Cipla EGFR-TKI Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Cipla Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 EGFR-TKI Industry Chain
12.2 EGFR-TKI Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 EGFR-TKI Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 EGFR-TKI Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 EGFR-TKI Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global EGFR-TKI Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global EGFR-TKI Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global EGFR-TKI Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global EGFR-TKI Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global EGFR-TKI Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global EGFR-TKI Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global EGFR-TKI Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global EGFR-TKI Sales by Region (2020-2025) & (K Units)
Table 8. Global EGFR-TKI Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global EGFR-TKI Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global EGFR-TKI Sales Share by Manufacturers (2020-2025)
Table 12. Global EGFR-TKI Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global EGFR-TKI Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global EGFR-TKI by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR-TKI as of 2024)
Table 16. Global EGFR-TKI Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global EGFR-TKI Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers EGFR-TKI Manufacturing Base and Headquarters
Table 19. Global EGFR-TKI Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global EGFR-TKI Sales by Type (2020-2025) & (K Units)
Table 23. Global EGFR-TKI Sales by Type (2026-2031) & (K Units)
Table 24. Global EGFR-TKI Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global EGFR-TKI Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global EGFR-TKI ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global EGFR-TKI Sales by Application (2020-2025) & (K Units)
Table 29. Global EGFR-TKI Sales by Application (2026-2031) & (K Units)
Table 30. EGFR-TKI High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global EGFR-TKI Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global EGFR-TKI Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global EGFR-TKI ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America EGFR-TKI Growth Accelerators and Market Barriers
Table 37. North America EGFR-TKI Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America EGFR-TKI Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe EGFR-TKI Growth Accelerators and Market Barriers
Table 40. Europe EGFR-TKI Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe EGFR-TKI Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific EGFR-TKI Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific EGFR-TKI Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific EGFR-TKI Growth Accelerators and Market Barriers
Table 45. Southeast Asia EGFR-TKI Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America EGFR-TKI Investment Opportunities and Key Challenges
Table 47. Central and South America EGFR-TKI Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa EGFR-TKI Investment Opportunities and Key Challenges
Table 49. Middle East and Africa EGFR-TKI Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. AstraZeneca Corporation Information
Table 51. AstraZeneca Description and Major Businesses
Table 52. AstraZeneca Product Models, Descriptions and Specifications
Table 53. AstraZeneca Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. AstraZeneca Sales Value Proportion by Product in 2024
Table 55. AstraZeneca Sales Value Proportion by Application in 2024
Table 56. AstraZeneca Sales Value Proportion by Geographic Area in 2024
Table 57. AstraZeneca EGFR-TKI SWOT Analysis
Table 58. AstraZeneca Recent Developments
Table 59. Roche Corporation Information
Table 60. Roche Description and Major Businesses
Table 61. Roche Product Models, Descriptions and Specifications
Table 62. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Roche Sales Value Proportion by Product in 2024
Table 64. Roche Sales Value Proportion by Application in 2024
Table 65. Roche Sales Value Proportion by Geographic Area in 2024
Table 66. Roche EGFR-TKI SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Betta Pharma Corporation Information
Table 69. Betta Pharma Description and Major Businesses
Table 70. Betta Pharma Product Models, Descriptions and Specifications
Table 71. Betta Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Betta Pharma Sales Value Proportion by Product in 2024
Table 73. Betta Pharma Sales Value Proportion by Application in 2024
Table 74. Betta Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. Betta Pharma EGFR-TKI SWOT Analysis
Table 76. Betta Pharma Recent Developments
Table 77. Boehringer Ingelheim Pharmaceuticals Corporation Information
Table 78. Boehringer Ingelheim Pharmaceuticals Description and Major Businesses
Table 79. Boehringer Ingelheim Pharmaceuticals Product Models, Descriptions and Specifications
Table 80. Boehringer Ingelheim Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Boehringer Ingelheim Pharmaceuticals Sales Value Proportion by Product in 2024
Table 82. Boehringer Ingelheim Pharmaceuticals Sales Value Proportion by Application in 2024
Table 83. Boehringer Ingelheim Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 84. Boehringer Ingelheim Pharmaceuticals EGFR-TKI SWOT Analysis
Table 85. Boehringer Ingelheim Pharmaceuticals Recent Developments
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Product Models, Descriptions and Specifications
Table 89. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Pfizer Sales Value Proportion by Product in 2024
Table 91. Pfizer Sales Value Proportion by Application in 2024
Table 92. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 93. Pfizer EGFR-TKI SWOT Analysis
Table 94. Pfizer Recent Developments
Table 95. Chengdu Brilliant Pharmaceuticals Corporation Information
Table 96. Chengdu Brilliant Pharmaceuticals Description and Major Businesses
Table 97. Chengdu Brilliant Pharmaceuticals Product Models, Descriptions and Specifications
Table 98. Chengdu Brilliant Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Chengdu Brilliant Pharmaceuticals Recent Developments
Table 100. Hansoh Pharma Corporation Information
Table 101. Hansoh Pharma Description and Major Businesses
Table 102. Hansoh Pharma Product Models, Descriptions and Specifications
Table 103. Hansoh Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Hansoh Pharma Recent Developments
Table 105. ArriVent Biopharma Corporation Information
Table 106. ArriVent Biopharma Description and Major Businesses
Table 107. ArriVent Biopharma Product Models, Descriptions and Specifications
Table 108. ArriVent Biopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. ArriVent Biopharma Recent Developments
Table 110. Hanmi Pharmaceutical Corporation Information
Table 111. Hanmi Pharmaceutical Description and Major Businesses
Table 112. Hanmi Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Hanmi Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Hanmi Pharmaceutical Recent Developments
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Major Businesses
Table 117. Johnson & Johnson Product Models, Descriptions and Specifications
Table 118. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Johnson & Johnson Recent Developments
Table 120. Yuhan Corporation Corporation Information
Table 121. Yuhan Corporation Description and Major Businesses
Table 122. Yuhan Corporation Product Models, Descriptions and Specifications
Table 123. Yuhan Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Yuhan Corporation Recent Developments
Table 125. Shanghai Allist Pharmaceuticals Corporation Information
Table 126. Shanghai Allist Pharmaceuticals Description and Major Businesses
Table 127. Shanghai Allist Pharmaceuticals Product Models, Descriptions and Specifications
Table 128. Shanghai Allist Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Shanghai Allist Pharmaceuticals Recent Developments
Table 130. Wanbang Biopharmaceuticals Corporation Information
Table 131. Wanbang Biopharmaceuticals Description and Major Businesses
Table 132. Wanbang Biopharmaceuticals Product Models, Descriptions and Specifications
Table 133. Wanbang Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Wanbang Biopharmaceuticals Recent Developments
Table 135. Beacon Pharma Corporation Information
Table 136. Beacon Pharma Description and Major Businesses
Table 137. Beacon Pharma Product Models, Descriptions and Specifications
Table 138. Beacon Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Beacon Pharma Recent Developments
Table 140. Drug International Corporation Information
Table 141. Drug International Description and Major Businesses
Table 142. Drug International Product Models, Descriptions and Specifications
Table 143. Drug International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Drug International Recent Developments
Table 145. Teva Corporation Information
Table 146. Teva Description and Major Businesses
Table 147. Teva Product Models, Descriptions and Specifications
Table 148. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Teva Recent Developments
Table 150. Mylan Corporation Information
Table 151. Mylan Description and Major Businesses
Table 152. Mylan Product Models, Descriptions and Specifications
Table 153. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Mylan Recent Developments
Table 155. Glenmark Pharmaceuticals Corporation Information
Table 156. Glenmark Pharmaceuticals Description and Major Businesses
Table 157. Glenmark Pharmaceuticals Product Models, Descriptions and Specifications
Table 158. Glenmark Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Glenmark Pharmaceuticals Recent Developments
Table 160. Cipla Corporation Information
Table 161. Cipla Description and Major Businesses
Table 162. Cipla Product Models, Descriptions and Specifications
Table 163. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Cipla Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources


List of Figures
Figure 1. EGFR-TKI Product Picture
Figure 2. Global EGFR-TKI Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Gefitinib Product Picture
Figure 4. Erlotinib Product Picture
Figure 5. Icotinib Product Picture
Figure 6. Afatinib Product Picture
Figure 7. Dacomitinib Product Picture
Figure 8. Osimertinib Product Picture
Figure 9. Aumolertinib Product Picture
Figure 10. Furmonertinib Product Picture
Figure 11. Lazertinib Product Picture
Figure 12. Global EGFR-TKI Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Hospital and Clinic
Figure 14. Retail Pharmacies
Figure 15. Other
Figure 16. EGFR-TKI Report Years Considered
Figure 17. Global EGFR-TKI Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 19. Global EGFR-TKI Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 20. Global EGFR-TKI Revenue Market Share by Region (2020-2031)
Figure 21. Global EGFR-TKI Sales (2020-2031) & (K Units)
Figure 22. Global EGFR-TKI Sales (CAGR) by Region (2020-2031) (K Units)
Figure 23. Global EGFR-TKI Sales Market Share by Region (2020-2031)
Figure 24. Top 5 and Top 10 Manufacturers EGFR-TKI Sales Volume Market Share in 2024
Figure 25. Global EGFR-TKI Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Gefitinib Revenue Market Share by Manufacturer in 2024
Figure 28. Erlotinib Revenue Market Share by Manufacturer in 2024
Figure 29. Icotinib Revenue Market Share by Manufacturer in 2024
Figure 30. Afatinib Revenue Market Share by Manufacturer in 2024
Figure 31. Dacomitinib Revenue Market Share by Manufacturer in 2024
Figure 32. Osimertinib Revenue Market Share by Manufacturer in 2024
Figure 33. Aumolertinib Revenue Market Share by Manufacturer in 2024
Figure 34. Furmonertinib Revenue Market Share by Manufacturer in 2024
Figure 35. Lazertinib Revenue Market Share by Manufacturer in 2024
Figure 36. Global EGFR-TKI Sales Market Share by Type (2020-2031)
Figure 37. Global EGFR-TKI Revenue Market Share by Type (2020-2031)
Figure 38. Global EGFR-TKI Sales Market Share by Application (2020-2031)
Figure 39. Global EGFR-TKI Revenue Market Share by Application (2020-2031)
Figure 40. North America EGFR-TKI Sales YoY (2020-2031) & (K Units)
Figure 41. North America EGFR-TKI Revenue YoY (2020-2031) & (US$ Million)
Figure 42. North America Top 5 Manufacturers EGFR-TKI Sales Revenue (US$ Million) in 2024
Figure 43. North America EGFR-TKI Sales Volume (K Units) by Type (2020- 2031)
Figure 44. North America EGFR-TKI Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 45. North America EGFR-TKI Sales Volume (K Units) by Application (2020-2031)
Figure 46. North America EGFR-TKI Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. US EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 48. Canada EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 49. Mexico EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 50. Europe EGFR-TKI Sales YoY (2020-2031) & (K Units)
Figure 51. Europe EGFR-TKI Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Europe Top 5 Manufacturers EGFR-TKI Sales Revenue (US$ Million) in 2024
Figure 53. Europe EGFR-TKI Sales Volume (K Units) by Type (2020-2031)
Figure 54. Europe EGFR-TKI Sales Revenue (US$ Million) by Type (2020-2031)
Figure 55. Europe EGFR-TKI Sales Volume (K Units) by Application (2020-2031)
Figure 56. Europe EGFR-TKI Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Germany EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 58. France EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 59. U.K. EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 60. Italy EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 61. Russia EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific EGFR-TKI Sales YoY (2020-2031) & (K Units)
Figure 63. Asia-Pacific EGFR-TKI Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Asia-Pacific Top 8 Manufacturers EGFR-TKI Sales Revenue (US$ Million) in 2024
Figure 65. Asia-Pacific EGFR-TKI Sales Volume (K Units) by Type (2020- 2031)
Figure 66. Asia-Pacific EGFR-TKI Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 67. Asia-Pacific EGFR-TKI Sales Volume (K Units) by Application (2020-2031)
Figure 68. Asia-Pacific EGFR-TKI Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Indonesia EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 70. Japan EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 71. South Korea EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 72. China Taiwan EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 73. India EGFR-TKI Revenue (2020-2031) & (US$ Million)
Figure 74. Central and South America EGFR-TKI Sales YoY (2020-2031) & (K Units)
Figure 75. Central and South America EGFR-TKI Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Central and South America Top 5 Manufacturers EGFR-TKI Sales Revenue (US$ Million) in 2024
Figure 77. Central and South America EGFR-TKI Sales Volume (K Units) by Type (2021-2031)
Figure 78. Central and South America EGFR-TKI Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Central and South America EGFR-TKI Sales Volume (K Units) by Application (2020-2031)
Figure 80. Central and South America EGFR-TKI Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. Brazil EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 82. Argentina EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 83. Middle East, and Africa EGFR-TKI Sales YoY (2020-2031) & (K Units)
Figure 84. Middle East and Africa EGFR-TKI Revenue YoY (2020-2031) & (US$ Million)
Figure 85. Middle East and Africa Top 5 Manufacturers EGFR-TKI Sales Revenue (US$ Million) in 2024
Figure 86. Middle East and Africa EGFR-TKI Sales Volume (K Units) by Type (2021-2031)
Figure 87. South America EGFR-TKI Sales Revenue (US$ Million) by Type (2020-2031)
Figure 88. Middle East and Africa EGFR-TKI Sales Volume (K Units) by Application (2020-2031)
Figure 89. Middle East and Africa EGFR-TKI Sales Revenue (US$ Million) by Application (2020-2031)
Figure 90. GCC Countries EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 91. Turkey EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 92. Egypt EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 93. South Africa EGFR-TKI Revenue (2020-2025) & (US$ Million)
Figure 94. EGFR-TKI Industry Chain Mapping
Figure 95. Regional EGFR-TKI Manufacturing Base Distribution (%)
Figure 96. Global EGFR-TKI Production Market Share by Region (2020-2031)
Figure 97. EGFR-TKI Production Process
Figure 98. Regional EGFR-TKI Production Cost Structure
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit